RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric Cancers The Phase 1 First-In-Human study is designed to assess the safety, tolerability & preliminary clinical activity of …